OTLK
HealthcareOutlook Therapeutics, Inc.
$0.54
$-0.12 (-17.73%)
Jan 5, 2026
Price History (1Y)
Analysis
Outlook Therapeutics, Inc. is a biotechnology company operating in the healthcare sector with a market capitalization of $86.18M and 23 employees. As a relatively small company within its industry, Outlook Therapeutics focuses on developing treatments for various conditions. The available financial data do not provide specific metrics for profitability, returns, or balance sheet indicators such as margins, ROE/ROA, debt to equity ratio, and cash levels. Similarly, revenue, net income, EBITDA, free cash flow, and dividend-related information are not provided. Outlook Therapeutics' valuation is not easily determinable with the available data, which does not include P/E ratios or price metrics beyond market capitalization, 52-week high/low prices, and a beta of 0.18, indicating relatively low volatility compared to the overall market.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is headquartered in Iselin, New Jersey.
Visit website →Key Statistics
- Market Cap
- $86.18M
- P/E Ratio
- N/A
- 52-Week High
- $3.39
- 52-Week Low
- $0.79
- Avg Volume
- 3.14M
- Beta
- 0.18
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 23